FDA warns against using prescription lidocaine for teething infants and children
The U.S. Food and Drug Administration issued a warning against the use of prescription oral viscous lidocaine 2 percent solution to treat infants and children with teething pain. They’ve also required a new boxed warning to be included on the drug’s label that highlights the potential risks.
Viscous lidocaine is a gel-like medication commonly prescribed to adults to treat pain from mouth and throat ulcers. However, its use in teething children is dangerous and could even be fatal in some cases.
“Topical pain relievers and medications that are rubbed on the gums are not necessary or even useful because they wash out of the baby’s mouth within minutes,” said the FDA in its statement. Accidental ingestion of the drug could result in seizures, severe brain injury, heart problems and even death in children.
Common symptoms can include jitteriness, confusion, vision problems, vomiting, falling asleep too easily and shaking. These symptoms can also increase the risk of choking or breathing in food. This current warning follows the FDA’s warning about benzocaine OTC products back in 2011.
To read the full statement from the FDA, click here.